DoW Spinal Cord Injury, Clinical Trial Award
Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of spinal cord injury (SCI). Distinctive Features: This funding opportunity cont
| Agency | Dept. of the Army -- USAMRAA |
|---|---|
| Status | Posted |
| Opportunity number | HT942526SCIRPCTA |
| Posted date | 05/05/2026 |
| Application deadline | Nov 12, 2026 12:00:00 AM EST |
| Award ceiling | none |
| Award floor | none |
| Estimated total funding | 9,760,000 |
| Expected number of awards | 2 |
| Assistance Listing (CFDA) | 12.420 |
| Description | Summary: The fiscal year 2026 (FY26) Spinal Cord Injury Research Program (SCIRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of spinal cord injury (SCI). Distinctive Features: This funding opportunity contains an Early-Career Partnership Option, which allows for two Principal Investigators (PIs). If this option is selected, at least one of the named PIs must be an early-career investigator. Only the Initiating PI will submit a pre-application, but all PIs will need to submit full applications. The Partnering PI’s application is an abbreviated package specific to their distinct portion of the research project. If recommended for funding, each PI will be named on a separate awar |
| Agency contact | help@eBRAP.org |
| Official listing | https://www.grants.gov/search-results-detail/362224 |